Cost-Effectiveness of Magnetic Resonance Imaging with a New Contrast Agent for the Early Diagnosis of Alzheimer's Disease

BACKGROUND: Used as contrast agents for brain magnetic resonance imaging (MRI), markers for beta-amyloid deposits might allow early diagnosis of Alzheimer's disease (AD). We evaluated the cost-effectiveness of such a diagnostic test, MRI+CLP (contrastophore-linker-pharmacophore), should it beco...

Descripción completa

Detalles Bibliográficos
Autores principales: Biasutti, Maria, Dufour, Natacha, Ferroud, Clotilde, Dab, William, Temime, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332046/
https://www.ncbi.nlm.nih.gov/pubmed/22532859
http://dx.doi.org/10.1371/journal.pone.0035559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332046/
https://www.ncbi.nlm.nih.gov/pubmed/22532859
http://dx.doi.org/10.1371/journal.pone.0035559

Ejemplares similares